CardioWear: A Wearable System for Ambulatory Cardiac Monitoring (aECG)

描述（由申请人提供）：Orbital Research提议开发一种完全可穿戴的传感器，称为CardioWear的动态心电图监测设备，以实现在家庭/动态条件下的连续心电生理监测。CardioWear将是一种可穿戴的服装设备，配备了Orbital Research的干ECG电极，用于长时间监测心率和节律、心率变异性和心脏事件等心脏标志物。CardioWear穿着舒适，容易穿脱，使用和维护方便。该平台线束部分是为NASA应用的急性心电图监测而开发的。ORI将使用定制设计的超低功耗、机器对机器电子数据收发模块将心电数据向上连接到蜂窝网络（即Sprint的远程医疗解决方案），以连续分析、存储和显示记录的指标。云通信系统将允许实时检查和分析通过蜂窝门户收集和发送的aECG数据。该系统的预期用途是用于中至高风险患者，可以从疾病管理和预防医学原因的持续监测中受益。总体而言，其目的是开发一种可穿戴平台，其性能优于传统的动态事件或基于胶带/凝胶电极的动态心电图监测仪。CardioWear的行业驱动力包括当前的医疗保健计划，这些计划的重点是改善响应时间，为心脏病患者提供更好的护理。通过提高监测能力，CardioWear将降低医疗成本，改善治疗效果并挽救生命。

DESCRIPTION (provided by applicant): Orbital Research proposes the development of a fully wearable sensor, ambulatory ECG monitoring device called CardioWear to enable continuous cardio- electrophysiology monitoring in home/ambulatory based conditions. CardioWear will be a wearable-garment device, equipped with Orbital Research dry ECG electrodes to monitor cardiac markers such as heart rate and rhythm, heart rate variability and cardiac events for long duration. CardioWear will be comfortable to wear, easy to don and doff, convenient to use and maintain. The platform harness has in part been developed for acute ECG monitoring for NASA applications. ORI will use a custom designed ultra-low power, machine to machine electronic data transceiver module to up-link aECG data to a cellular network (i.e Sprint's Telehealth Solutions) for continuous analysis, storage and display of the recorded metrics. The cloud communication system will allow real-time inspection and analysis of aECG data collected and sent through the cellular portal. The intended use of the system is for moderate-to-high risk patients that can benefit from continuous monitoring for both disease management and preventive medicine reasons. Overall, the intent is to develop a wearable platform that outperforms conventional ambulatory event or Holter monitors which depend on adhesive tape/gel-based electrodes. The industry driver for CardioWear includes current health care initiatives which are focused on improving response time and providing better care for cardiac patients. By improving monitoring capabilities, CardioWear will reduce health care costs, improve outcomes and save lives. PUBLIC HEALTH RELEVANCE: Cardio Wear system provides a feasible solution for the established clinical and technical needs currently associated, vastly limiting aECG studies. The resultant Cardio Wear platform will improve patient compliance, reduce disease and treatment related costs, advance monitoring and diagnostic capabilities, all these together will improve the outcomes for the patients. Keywords: aECG, Holter, electrode, telemetry, ambulatory